|
1
|
Liu JKH: The history of monoclonal
antibody development-Progress, remaining challenges and future
innovations. Ann Med Surg (Lond). 3:113–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martinelli E, De Palma R, Orditura M, De
Vita F and Ciardiello F: Anti-epidermal growth factor receptor
monoclonal antibodies in cancer therapy. Clin Exp Immunol. 158:1–9.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niu G and Chen X: Vascular endothelial
growth factor as an anti-angiogenic target for cancer therapy. Curr
Drug Targets. 11:1000–1017. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bennouna J, Sastre J, Arnold D, Österlund
P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C,
et al: ML18147 Study investigators: Continuation of bevacizumab
after first progression in metastatic colorectal cancer (ML18147):
A randomised phase 3 trial. Lancet Oncol. 14:29–37. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Schmitz KR, Jeffrey PD, Wiltzius
JJW, Kussie P and Ferguson KM: Structural basis for inhibition of
the epidermal growth factor receptor by cetuximab. Cancer Cell.
7:301–311. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van Dongen GA, Visser GWM, Lub-de Hooge
MN, de Vries EG and Perk LR: Immuno-PET: A navigator in monoclonal
antibody development and applications. Oncologist. 12:1379–1389.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arruebo M, Valladares M and
González-Fernández Á: Antibody-conjugated nanoparticles for
biomedical applications. J Nanomater. 2009:2009. View Article : Google Scholar
|
|
9
|
Andersson K: Bringing time into molecular
and cellular biology. J Anal Oncol. 2:65–68. 2013.
|
|
10
|
Kastritis PL and Bonvin AMJJ: On the
binding affinity of macromolecular interactions: Daring to ask why
proteins interact. J R Soc Interface. 10:201208352013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Renaud JP, Chung CW, Danielson UH, Egner
U, Hennig M, Hubbard RE and Nar H: Biophysics in drug discovery:
Impact, challenges and opportunities. Nat Rev Drug Discov.
15:679–698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Björke H and Andersson K: Measuring the
affinity of a radioligand with its receptor using a rotating cell
dish with in situ reference area. Appl Radiat Isot. 64:32–37. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stenberg J, Spiegelberg D, Karlsson H and
Nestor M: Choice of labeling and cell line influences interactions
between the Fab fragment AbD15179 and its target antigen CD44v6.
Nucl Med Biol. 41:140–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spiegelberg D, Stenberg J, Haylock AK and
Nestor M: A real-time in vitro assay as a potential predictor of in
vivo tumor imaging properties. Nucl Med Biol. 43:12–18. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nath N, Godat B, Zimprich C, Dwight SJ,
Corona C, McDougall M and Urh M: Homogeneous plate based antibody
internalization assay using pH sensor fluorescent dye. J Immunol
Methods. 431:11–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Perera RM, Zoncu R, Johns TG, Pypaert M,
Lee FT, Mellman I, Old LJ, Toomre DK and Scott AM: Internalization,
intracellular trafficking, and biodistribution of monoclonal
antibody 806: A novel anti-epidermal growth factor receptor
antibody. Neoplasia. 9:1099–1110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Winquist J, Geschwindner S, Xue Y,
Gustavsson L, Musil D, Deinum J and Danielson UH: Identification of
structural-kinetic and structural-thermodynamic relationships for
thrombin inhibitors. Biochemistry. 52:613–626. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shuman CF, Hämäläinen MD and Danielson UH:
Kinetic and thermodynamic characterization of HIV-1 protease
inhibitors. J Mol Recognit. 17:106–119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Geitmann M and Danielson UH: Additional
level of information about complex interaction between
non-nucleoside inhibitor and HIV-1 reverse transcriptase using
biosensor-based thermodynamic analysis. Bioorg Med Chem.
15:7344–7354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reverberi R and Reverberi L: Factors
affecting the antigen-antibody reaction. Blood Transfus. 5:227–240.
2007.PubMed/NCBI
|
|
21
|
Björkelund H, Gedda L and Andersson K:
Comparing the epidermal growth factor interaction with four
different cell lines: Intriguing effects imply strong dependency of
cellular context. PLoS One. 6:e165362011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bondza S, Stenberg J, Nestor M, Andersson
K and Björkelund H: Conjugation effects on antibody-drug
conjugates: Evaluation of interaction kinetics in real time on
living cells. Mol Pharm. 11:4154–4163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gedda L, Björkelund H and Andersson K:
Real-time immunohistochemistry analysis of embedded tissue. Appl
Radiat Isot. 68:2372–2376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ekerljung L, Wållberg H, Sohrabian A,
Andersson K, Friedman M, Frejd FY, Ståhl S and Gedda L: Generation
and evaluation of bispecific affibody molecules for simultaneous
targeting of EGFR and HER2. Bioconjug Chem. 23:1802–1811. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pa̧zik R, Andersson R, Kȩpiński L, Nedelec
J-M, Kessler VG and Seisenbaeva GA: Surface functionalization of
the metal oxide nanoparticles with biologically active molecules
containing phosphonate moieties. Case study of BaTiO 3. J Phys Chem
C. 115:9850–9860. 2011. View Article : Google Scholar
|
|
26
|
Barta P, Malmberg J, Melicharova L,
Strandgård J, Orlova A, Tolmachev V, Laznicek M and Andersson K:
Protein interactions with HER-family receptors can have different
characteristics depending on the hosting cell line. Int J Oncol.
40:1677–1682. 2012.PubMed/NCBI
|
|
27
|
Fornstedt T: Characterization of
adsorption processes in analytical liquid-solid chromatography. J
Chromatogr A. 1217:792–812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ståhlberg J, Henriksson H, Divne C,
Isaksson R, Pettersson G, Johansson G and Jones TA: Structural
basis for enantiomer binding and separation of a common β-blocker:
Crystal structure of cellobiohydrolase Cel7A with bound
(S)-propranolol at 1.9 A resolution. J Mol Biol. 305:79–93. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fornstedt T and Guiochon G: Nonlinear
effects in LC and Chiral LC. Anal Chem. 73:608A–617A. 2001.
View Article : Google Scholar : PubMed/NCBI
|
